Entry | Author | Date | Location | |
---|---|---|---|---|
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More | Frank Vinluan | 04/24/20 | National | |
Ventrus Struggles to Reassure Street After Loss of Hemorrhoid Drug | Arlene Weintraub | 07/03/12 | New York | |
Ventrus Attracts Investors With Hemorrhoid Drug and Two Other Late-Stage Drug Candidates | Arlene Weintraub | 08/02/11 | New York | |
Page 1 of 1 | ||||